TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 111 resultados LastUpdate Última actualización 19/02/2020 [18:46:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

previousPage Página2 de 5 nextPage   por página


Diabetes management partner interface for wireless communication of analyte data

NºPublicación: AU2018362257A1 06/02/2020

Solicitante:

DEXCOM INC

US_2019173885_A1

Resumen de: AU2018362257A1

Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT DEVICE

NºPublicación: WO2020027433A1 06/02/2020

Solicitante:

I SENS INC [KR]

Resumen de: WO2020027433A1

The present invention relates to a continuous blood glucose measurement device which is produced with an assembled body attachment unit inside an applicator so as to minimize a user's additional work of attaching the body attachment unit to the body, thereby enabling the body attachment unit to be attached to the body by simply activating the applicator, and, particularly, the present invention provides a continuous blood glucose measurement device which: is provided with a wireless communication chip in a body attachment unit so as to enable communication with an external terminal, thereby enabling simple and convenient use, without additional work of connecting a separate transmitter, and easier maintenance; and is activated by the user after the body attachment unit is attached to the body so as to enable the operation start time to be adjusted to an appropriate time according to user's needs, and to enable the operation to start in a stabilized state so that blood glucose can be measured more accurately.

traducir

SYSTEM AND METHOD FOR CONTROLLING BLOOD GLUCOSE USING PERSONALIZED HISTOGRAMS

NºPublicación: EP3603509A1 05/02/2020

Solicitante:

CNOGA MEDICAL LTD [IL]

Resumen de: EP3603509A1

A method of control of diabetes in a patient, comprising: measuring, using a non-invasive or invasive glucose measuring device, momentary glucose levels of the patient at multiple times a day during an initial time period either continuously or at discrete times, the initial time period being at least a week; recording the momentary glucose levels in a memory in communication with the device, the recording including optional information associated with a recent temporal glucose reading wherein the optional information including one or more of the following information: date, time, time of recent food eating, recent physical activity, diabetes treatment, body temperature, blood pressure, pulse, and drugs associated with the recent temporal glucose reading; constructing, using one or more processors in communication with the device, current curvilinear probability density functions of occurrences of the momentary glucose levels throughout the initial time period and displaying the curvilinear probability density functions on a screen; determining, using one or more processors, a quantitative assessment of at least one of the following current momentary markers during the measurement period from the momentary glucose levels recorded and the optional information: (i) Insulin Resistance (IR), (ii) Glucose Variability (GV), (iii) Glucose Severity Index (GSI) or (iv) Glucose Burden (GB), and constructing, using the one or more processors, a personalized target curvilinear probabilit

traducir

PATIENT-SPECIFIC GLUCOSE PREDICTION SYSTEMS AND METHODS

NºPublicación: EP3600036A1 05/02/2020

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2018272066_A1

Resumen de: WO2018175935A1

Infusion devices and related medical devices, patient data management systems, and methods are provided for monitoring a physiological condition of a patient. One exemplary method of monitoring a physiological condition of a patient involves obtaining current measurement data for the physiological condition of the patient provided by a sensing arrangement, obtaining a user input indicative of one or more future events associated with the patient, and in response to the user input, determining a prediction of the physiological condition of the patient in the future based at least in part on the current measurement data and the one or more future events using one or more prediction models associated with the patient, and displaying a graphical representation of the prediction on a display device.

traducir

MAINTAINING MAXIMUM DOSING LIMITS FOR CLOSED LOOP INSULIN MANAGEMENT SYSTEMS

NºPublicación: EP3600037A1 05/02/2020

Solicitante:

ANIMAS CORP [US]

KR_20190137844_A

Resumen de: US2018280619A1

A system and a method for management of diabetes are provided. The system includes an infusion pump, glucose sensor, and controller that is programmed to control insulin delivery based upon at least one stored variable. The controller calculates a maximum insulin delivery rate based on the default basal insulin delivery rate, temporary basal insulin delivery rate, extended bolus rate, or a combination thereof.

traducir

Methods, Devices and System for Providing Diabetic Condition Diagnosis and Therapy

NºPublicación: EP3600014A1 05/02/2020

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2018271418_PA

Resumen de: US2018271418A1

Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.

traducir

CONTINUOUS GLUCOSE MONITORING ON-BODY SENSOR

NºPublicación: EP3603511A2 05/02/2020

Solicitante:

BECTON DICKINSON CO [US]

JP_2019134947_A

Resumen de: EP3603511A2

An on-body sensor (OBS) (5610) having a continuous monitoring (CGM) device is disclosed for use in identifying an analyte, such as glucose in blood or interstitial fluid (ISF), using a biomaterial, such as glucose binding protein (GBP), that is brought into contact with the analyte. The on-body sensor (5610) incorporating the CGM device includes a housing (5625') which provides protection to the CGM device while providing comfort to a user wearing the device. The OBS also includes an adhesive structure that provides a comfortable, discreet and secure user experience.

traducir

APPARATUS AND METHOD FOR DETERMINING BLOOD GLUCOSE CONCENTRATION

NºPublicación: KR20200010991A 31/01/2020

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: KR20200010991A

비침습적으로 혈당 농도를 결정하는 방법과 관련된다. 일 실시예에 따르면, 혈당 농도를 결정하는 방법은 근적외선 스펙트럼 및 순수 스펙트럼을 처리하여 전처리된 근적외선 스펙트럼을 획득하는 단계, 전처리된 근적외선 스펙트럼으로부터 주요 특징 셋을 추출하는 단계, 검증 데이터의 복수의 균질화된 특징 셋을 획득하는 단계 및, 복수의 대상들에 대한 훈련 데이터 및 검증 데이터의 균질화된 특징 셋을 이용하여 피검체의 혈당 농도를 결정하는 단계를 포함할 수 있다.

traducir

Method for diagnosing exocrine pancreatic insufficiency in patients with type 1 diabetes mellitus

NºPublicación: MD1411Y 31/01/2020

Solicitante:

USMF NICOLAE TESTEMITANU REPUBLICA MOLDOVA [MD]
INST DE CARDIOLOGIE DIN REPUBLICA MOLDOVA [MD]

Resumen de: MD1411Y

The invention relates to medicine, in particular to gastroenterology and endocrinology.Summary of the invention consists in establishing the duration of diabetes mellitus (DDM) and in conducting the paraclinical examination, where the value of plasma albumin (ALB), of serum lipase (LPS) and of C-reactive protein (CRP) in the blood is determined and the discriminant function (F) is calculated by the formula:F = -6.422 + 0.146; ALB + 0.070; LPS - 0.102; DDM - 0.234; CRP,and if F<0, the presence of exocrine pancreatic insufficiency is diagnosed, and if F>0, the absence of exocrine pancreatic insufficiency is diagnosed in patients with type 1 diabetes mellitus.

traducir

DISPOSABLE ANTI-PUNCTURING INSULIN INJECTION NEEDLE AND ANTI-PUNCTURING METHOD

NºPublicación: WO2020019154A1 30/01/2020

Solicitante:

JIANGSU CAINA MEDICAL CO \uFF0CLTD [CN]

CN_109496158_A

Resumen de: WO2020019154A1

A disposable anti-puncturing insulin injection needle, comprising a housing (10), a needle seat (20), an injection needle (21), a needle tip protection sleeve (30), an elastic member (1), a sliding sleeve (50), and an anti-withdrawal claw (60); the sliding sleeve (50) is sleeved over the needle seat (20), the anti-withdrawal claw (60) is fixedly connected to the needle seat (20) and comprises a claw portion (62) that is at least partially located at the exterior of the sliding sleeve (50) and that opens outward; when the needle tip protection sleeve (30) is pressed to move toward the needle seat (20), the elastic member (1) is pressed to deform and hook to the sliding sleeve (50); when the pressure is removed, the elastic element (1) pushes the needle tip protection sleeve (30) to move and drives the sliding sleeve (50) to detach from the anti-withdrawal claw (60), and the anti-withdrawal claw (60) is restored to the original state to prevent the sliding sleeve (50) and the needle tip protection sleeve (30) from moving downward. The injection needle may reliably self-lock after use, and is safer.

traducir

PERITONEAL DIALYSIS SYSTEM WITH SENSORS AND CONFIGURED TO DIAGNOSE PERITONITIS

NºPublicación: WO2020023754A1 30/01/2020

Solicitante:

BAXTER INT [US]
BAXTER HEALTHCARE SA [CH]

US_2020030517_A1

Resumen de: WO2020023754A1

Peritoneal dialysis, such as automated peritoneal dialysis ("APD") is provided with any one or more or all of the following sensing or feedback features: impedance sensing to detect peritonitis, temperature sensing to detect peritonitis, bio-MEMS sensing to detect peritonitis, and glucose control for diabetes patients, wherein each sensing or feedback feature analyzes patient effluent fluid or fluid dwelling within a patient's peritoneal cavity.

traducir

DIALYSIS AND METHODS INCLUDING SENSOR FEEDBACK TO IMPROVE PATIENT EXPERIENCE

NºPublicación: US2020030517A1 30/01/2020

Solicitante:

BAXTER INT [US]
BAXTER HEALTHCARE SA [CH]

WO_2020023754_A1

Resumen de: US2020030517A1

Peritoneal dialysis, such as automated peritoneal dialysis (“APD”) is provided with any one or more or all of the following sensing or feedback features: impedance sensing to detect peritonitis, temperature sensing to detect peritonitis, bio-MEMS sensing to detect peritonitis, and glucose control for diabetes patients, wherein each sensing or feedback feature analyzes patient effluent fluid or fluid dwelling within a patient's peritoneal cavity.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2020029867A1 30/01/2020

Solicitante:

MASIMO CORP [US]

US_2020015716_A1

Resumen de: US2020029867A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

DUAL ELECTRODE SYSTEM FOR A CONTINUOUS ANALYTE SENSOR

NºPublicación: US2020029876A1 30/01/2020

Solicitante:

DEXCOM INC [US]

US_2019110724_A1

Resumen de: US2020029876A1

Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure additional analyte or non-analyte related signal. Such measurements may provide a background and/or sensitivity measurement(s) for use in processing sensor data and may be used to trigger events such as digital filtering of data or suspending display of data.

traducir

NONENZYMATIC DETERMINATION OF GLUCOSE AT NEAR NEUTRAL PH VALUES BASED ON THE USE OF NAFION AND PLATINUM BLACK COATED MICRONEEDLE ELECTRODE ARRAY

NºPublicación: US2020029869A1 30/01/2020

Solicitante:

UNIV GACHON IND ACAD COOP FOUND [KR]

Resumen de: US2020029869A1

Provided are a microneedle electrode sensor for nonenzymatic monitoring of blood sugar, a method of manufacturing the sensor, and a method of nonenzymatically measuring blood sugar using the sensor. The method of manufacturing the microneedle electrode sensor includes (a) forming multiple microneedle shapes in a substrate, (b) coating the entire area of the substrate with a passivation agent, and (c) coating a microneedle reactive portion disposed at a tip of each microneedle with a glucose oxidation catalyst.

traducir

METHOD OF ADJUSTING MEDICATION DOSES

NºPublicación: WO2020023473A1 30/01/2020

Solicitante:

SANOFI SA [FR]

Resumen de: WO2020023473A1

Method, apparatus and system for adjusting medicament doses. A method of providing a medication dose adjustment using a computing device comprises: receiving an adjustment cycle time period; receiving a threshold number of dose and blood glucose measurement pairs, the threshold number of dose and blood glucose measurement pairs being less than a total number of potential dose and blood glucose measurement pairs possible in the adjustment time cycle period; receiving a dose and blood glucose measurement pair; determining if a total number of dose and blood glucose measurement pairs received within a current adjustment cycle time period meets the threshold number, the current adjustment cycle time period depending on the received adjustment cycle time period; in response to a positive determination, determining if a dose adjustment is required based on the dose and blood glucose measurement pairs received within an adjustment cycle time period; and outputting the dose adjustment.

traducir

LANCET DEVICE WITH FIRST-DROP REMOVAL

NºPublicación: EP3598944A1 29/01/2020

Solicitante:

BECTON DICKINSON CO [US]

AU_2018220065_A1

Resumen de: EP3598944A1

A medical puncturing device (10) having a wicking element (300) disposed on a portion of the medical puncturing device is disclosed. The wicking element allows a user to remove a first drop of blood upon puncturing the skin using the medical puncturing device. In this manner, a subsequent drop of blood can be used to test their blood to determine their blood glucose level for proper insulin dosing.

traducir

METHODS AND SYSTEMS FOR PERFORMING UNIVERSAL CALIBRATION TO NON-INVASIVELY DETERMINE BLOOD GLUCOSE CONCENTRATION

NºPublicación: US2020022627A1 23/01/2020

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: US2020022627A1

A method includes processing near infrared spectroscopy (NIR) spectra and pure spectra, to obtain a preprocessed NIR spectra, wherein the preprocessed NIR spectra includes any one or any combination of a training data of a plurality of subjects, a calibration data of a test subject and a validation data of the test subject, extracting a dominant feature set from the preprocessed NIR spectra, wherein the dominant feature set includes at least one preprocessed NIR spectrum corresponding to each of the training data, the calibration data and the validation data, and determining a blood glucose concentration of the test subject, using the training data of the plurality of subjects and based on the extracted dominant feature set.

traducir

SYSTEM, METHOD, AND COMPUTER READABLE MEDIUM FOR DYNAMIC INSULIN SENSITIVITY IN DIABETIC PUMP USERS

NºPublicación: US2020023126A1 23/01/2020

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

US_2017056591_PA

Resumen de: US2020023126A1

A technique for treating diabetes that recognizes patient insulin sensitivity is a time-varying physiological parameter. The described techniques for treating diabetes include measuring interstitial fluid glucose concentration, reading insulin delivery data, determining patient insulin sensitivity based on the interstitial fluid glucose concentration and insulin delivery data, and a time-varying physiological parameter, and dispensing an insulin dose from an insulin delivery device based on the determined patient insulin sensitivity.

traducir

Insulin Management

NºPublicación: US2020027544A1 23/01/2020

Solicitante:

ASEKO INC [US]

US_2019180858_A1

Resumen de: US2020027544A1

A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.

traducir

METHOD FOR DIFFERENTIATED SELECTION OF PATIENTS WITH DIABETES MELLITUS FOR THE PLANNED OPERATION OF TOTAL HIP AND/OR KNEE ENDOPROSTHETICS

NºPublicación: RU2712003C1 23/01/2020

Solicitante:

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NOVOSIBIRSKIJ NAUCHNO ISSLEDOVATELSKIJ INSTITUT [RU]

Resumen de: RU2712003C1

FIELD: medicine.SUBSTANCE: invention refers to medicine and can be used for differentiated selection of patients with diabetes mellitus for the planned operation of total hip and / or knee endoprosthetics. Glycated hemoglobin is pre-determined, and on the eve of the operation, intestinal murmurings are recorded on a computer phoneterogram and the peristalsis type is determined from the table. Patients with a moderate and severe type of peristalsis are referred for a planned operation. For the group of patients with mild type of peristalsis, the value of intestinal peak-factor is determined, then this group of patients is given food and sugar-lowering drugs. Thereafter, IPFvalue is determined again and IPFand IPFvalues are compared. Group of patients with IPFand IPFvalues differ by less than 30 %, are directed for the planned operation. Group of patients with IPFvalue decreased by more than 30 % of IPFvalue, preparations stimulating gastrointestinal motility, and sugar-lowering preparations are given. In 20-50 minutes after taking these preparations, the value of IPFis determined and IPFand IPFvalues are compared. Patients with IPFand IPFvalues differ by less than 30 %, directed to planned operation. For patients with IPFvalue lower than IPFvalue more than 30 % planned operation is transferred on the following day and IPFis determined again, if necessary IPFand IPFto achieve correct parameters.EFFECT: reduced postoperative risks.1 cl, 1 tbl

traducir

PREDICTING RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY WITH COMPUTER-EXTRACTED MORPHOLOGY AND SPATIAL ARRANGEMENT FEATURES OF LEAKAGE PATTERNS ON BASELINE FLUORESCEIN ANGIOGRAPHY IN DIABETIC MACULAR EDEMA

NºPublicación: US2020027209A1 23/01/2020

Solicitante:

UNIV CASE WESTERN RESERVE [US]
CLEVELAND CLINIC FOUND [US]

Resumen de: US2020027209A1

Embodiments facilitate prediction of anti-vascular endothelial growth (anti-VEGF) therapy response in DME patients. A first set of embodiments discussed herein relates to training of a machine learning classifier to determine a prediction for response to anti-VEGF therapy based on a set of graph-network features and a set of morphological features generated based on FA images of tissue demonstrating DME. A second set of embodiments discussed herein relates to determination of a prediction of response to anti-VEGF therapy for a DME patient (e.g., non-rebounder vs. rebounder, response vs. non-response) based on a set of graph-network features and a set of morphological features generated based on FA imagery of the patient.

traducir

PHYSIOLOGICAL INFORMATION ACQUISITION DEVICE AND SEX LIFE APPARATUS

NºPublicación: WO2020014831A1 23/01/2020

Solicitante:

XIU XIU TECH SHENZHEN CO LTD [CN]

Resumen de: WO2020014831A1

Provided are a physiological information acquisition device (1) and a sex life apparatus. The physiological information acquisition device (1) comprises a first master control module (10), a heart rate detection module (11), a blood oxygen detection module (12), a blood glucose detection module (13), a blood pressure detection module (14), a pressure detection module (15), a temperature detection module (16), an acceleration sensing module (17), and an angular velocity sensing module (18); the heart rate detection module (11), the blood oxygen detection module (12), the blood glucose detection module (13), the blood pressure detection module (14), the pressure detection module (15), the temperature detection module (16), the acceleration sensing module (17), and the angular velocity sensing module (18) are connected to the first master control module (10). The sex life apparatus comprises the physiological information acquisition device (1) and a sex life device (2). The physiological information acquisition device (1) and the sex life apparatus improve the user experience by changing the mode of the sex life device (2) according to human physiological information.

traducir

Evaluation of an amount of a substance contained within circulating blood

NºPublicación: GB2575718A 22/01/2020

Solicitante:

ZEDSEN LTD [GB]

US_2019365300_PA

Resumen de: GB2575718A

Apparatus for and method of determining an amount of a substance (i.e. glucose) contained in blood within human body tissue. Application region 105 of an apparatus makes skin contact, electrodes 106, which may be substantially parallel, present an active region. Force is measured by sensor (408 figure 4) and if sufficient force is applied selected pairs of electrodes are capacitively-coupled to the tissue, producing electric fields that penetrate the tissue and provide output data from which the amount of the substance is calculated. If insufficient or excessive force is applied coupling is inhibited, and the device may indicate that more or less force is necessary (figures 16 and 17). A second, orthogonal set of electrodes may be provided (figure 9). The transmitter and receiver electrodes may be scanned through via a multiplexer (figure 8) to penetrate different layers of the tissue (figure 20). Machine learning techniques may be applied to the data to calculate substance amounts.

traducir

SYSTEMS AND METHODS FOR DETERMINING INSULIN THERAPY FOR A PATIENT

Nº publicación: EP3598382A1 22/01/2020

Solicitante:

MONARCH MEDICAL TECH LLC [US]

AU_2012358357_A1

Resumen de: EP3598382A1

With a computing system, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

traducir

previousPage Página2 de 5 nextPage por página

punteroimgVolver